Anteris Technologies Global Corp.
AVR Nasdaq Orthopedic, Prosthetic & Surgical Appliances & Supplies Financials FY2024–FY2025
Revenue
Total sales reported in the income statement.
$1.9M
29.2%
vs prior year
Operating margin
Operating income as a share of revenue.
−4,908.2%
2,008.8 pts
Net income
Profit after all expenses, interest and tax.
−$94.1M
Free cash flow
Cash from operations minus capital spending.
−$79.8M
Return on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
—
Market cap
Last close times the latest diluted share count, so it is approximate.
—
P/E
Last close divided by diluted earnings per share over the last four quarters.
—
On −$1.94 EPS (TTM)
What Anteris Technologies Global Corp. does
No business description yet.
- Legal name
- Anteris Technologies Global Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Accession · CIK
- 0001140361-26-006977
0002011514
Revenue and margins
Anteris Technologies Global Corp. had $1.9M of revenue in fiscal 2025, down 29.2% on the year before.
FY24
Revenue $2.7M
FY25
Revenue $1.9M
Q1 '24
Revenue $0.8M
Q2 '24
Revenue $0.6M
Q3 '24
Revenue $0.8M
Q4 '24
Revenue $0.5M
Q1 '25
Revenue $0.6M
Q2 '25
Revenue $0.6M
Q3 '25
Revenue $0.4M
Q4 '25
Revenue $0.3M
Q1 '26
Revenue $0.5M
Q2 '26
Revenue $1.0M
FY24
Gross 46.8%
Operating −2,899.4%
Net −2,822.5%
FCF −2,349.5%
FY25
Gross 70.3%
Operating −4,908.2%
Net −4,921.3%
FCF −4,169.2%
Gross
Operating
Net
FCF
Q1 '24
Gross 38.3%
Operating −2,321.8%
Net −2,134.5%
FCF −2,121.3%
Q2 '24
Gross 50.6%
Operating −2,922.6%
Net −2,960.0%
FCF −2,217.9%
Q3 '24
Gross 42.4%
Operating −2,678.4%
Net −2,842.4%
FCF −1,903.8%
Q4 '24
Gross 61.2%
Operating −4,014.7%
Net −3,614.9%
FCF −3,470.3%
Q1 '25
Gross 62.8%
Operating −3,917.3%
Net −3,932.4%
FCF −3,909.5%
Q2 '25
Gross 76.1%
Operating −3,379.3%
Net −3,371.2%
FCF −3,247.9%
Q3 '25
Gross 71.3%
Operating −5,190.0%
Net −5,185.1%
FCF −4,434.5%
Q4 '25
Gross 70.6%
Operating −9,343.5%
Net −9,420.0%
FCF −6,104.5%
Q1 '26
Gross 76.9%
Operating −4,859.7%
Net −4,660.7%
FCF −5,833.4%
Q2 '26
Gross 76.9%
Operating −3,072.1%
Net −2,883.4%
FCF −2,125.4%
Gross
Operating
Net
FCF
Net income and earnings per share
Loss periods are shown in red.
FY24
Net income −$76.3M
FY25
Net income −$94.1M
Q1 '24
Net income −$16.4M
Q2 '24
Net income −$18.7M
Q3 '24
Net income −$21.9M
Q4 '24
Net income −$19.4M
Q1 '25
Net income −$21.9M
Q2 '25
Net income −$20.8M
Q3 '25
Net income −$22.2M
Q4 '25
Net income −$29.2M
Q1 '26
Net income −$23.0M
Q2 '26
Net income −$29.1M
FY24
Diluted EPS −$3.68
FY25
Diluted EPS −$2.55
Q1 '24
Diluted EPS −$0.91
Q2 '24
Diluted EPS −$0.98
Q3 '24
Diluted EPS −$1.07
Q4 '24
Diluted EPS −$0.72
Q1 '25
Diluted EPS −$0.61
Q2 '25
Diluted EPS −$0.58
Q3 '25
Diluted EPS −$0.62
Q4 '25
Diluted EPS −$0.74
Q1 '26
Diluted EPS −$0.28
Q2 '26
Diluted EPS −$0.30
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
FY24
Return on capital —
Return on equity −121.6%
Return on assets −94.5%
FY25
Return on capital —
Return on equity −300.5%
Return on assets −181.6%
Return on capital
Return on equity
Return on assets
Cash flow
Free cash flow was −$79.8M in fiscal 2025, −4,169.2% of revenue. Cash from operations minus capital spending.
FY24
Free cash flow −$63.5M
FY25
Free cash flow −$79.8M
Q1 '24
Free cash flow −$16.2M
Q2 '24
Free cash flow −$14.0M
Q3 '24
Free cash flow −$14.6M
Q4 '24
Free cash flow −$18.6M
Q1 '25
Free cash flow −$21.7M
Q2 '25
Free cash flow −$20.1M
Q3 '25
Free cash flow −$19.0M
Q4 '25
Free cash flow −$18.9M
Q1 '26
Free cash flow −$28.8M
Q2 '26
Free cash flow −$21.4M
FY24
Cash from operations −$61.2M
Capital spending $2.3M
FY25
Cash from operations −$77.8M
Capital spending $2.0M
Cash from operations
Capital spending
Q1 '24
Cash from operations −$15.5M
Capital spending $0.7M
Q2 '24
Cash from operations −$13.4M
Capital spending $0.6M
Q3 '24
Cash from operations −$14.1M
Capital spending $0.5M
Q4 '24
Cash from operations −$18.2M
Capital spending $0.4M
Q1 '25
Cash from operations −$21.5M
Capital spending $0.2M
Q2 '25
Cash from operations −$19.5M
Capital spending $0.5M
Q3 '25
Cash from operations −$18.3M
Capital spending $0.8M
Q4 '25
Cash from operations −$18.5M
Capital spending $0.4M
Q1 '26
Cash from operations −$28.7M
Capital spending $0.1M
Q2 '26
Cash from operations −$20.8M
Capital spending $0.6M
Cash from operations
Capital spending
Dividends, buybacks and share count
Anteris Technologies Global Corp. returned — to shareholders in fiscal 2025. The diluted share count rose 82.3%.
FY24
Dividends —
Buybacks —
FY25
Dividends —
Buybacks —
Dividends
Buybacks
FY24
Diluted shares 0.02B
FY25
Diluted shares 0.04B
Balance sheet
Cash, debt and the ratios that show how comfortably Anteris Technologies Global Corp. can carry it.
FY24
Cash $70.5M
Debt $0.0M
FY25
Cash $6.7M
Debt $0.0M
Cash
Debt
| Fiscal year end | FY24 | FY25 |
|---|---|---|
| Cash and short-term investments | $70.5M | $6.7M |
| Debt incl. finance leases | $0.0M | $0.0M |
| Debt / equity | 0.0x | — |
| Interest coverage | −1,667.5x | −1,286.2x |
| Current ratio | 4.5x | 0.7x |
| Quick ratio | 4.5x | 0.7x |
| Total assets | $80.7M | $23.0M |
| Total liabilities | $18.0M | $23.3M |
| Shareholders' equity | $62.8M | −$0.1M |
| Net debt (− = net cash) | −$70.5M | −$6.7M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | ✕ | ✕ |
| Cash from operations is positive | ✕ | ✕ |
| Return on assets rose | — | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ |
| Debt fell relative to assets | — | ✕ |
| Current ratio rose | — | ✕ |
| Share count didn't rise | — | ✕ |
| Gross margin rose | — | ✓ |
| Revenue rose relative to assets | — | ✓ |
| F-score | — / 3 | 3 / 9 |
| Accruals ratio | −18.6% | −31.5% |
| Altman Z'' | −9.31 | −81.59 |
2 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Income statement | ||
| Revenue | $2.7M | $1.9M |
| Gross profit | $1.3M | $1.3M |
| Research and development | $51.5M | $69.1M |
| Operating income | −$78.4M | −$93.9M |
| Interest expense | $0.0M | $0.1M |
| Pretax income | −$76.0M | −$94.2M |
| Income tax | $0.0M | $0.0M |
| Net income | −$76.3M | −$94.1M |
| Diluted EPS | −$3.68 | −$2.55 |
| Diluted shares | 0.02B | 0.04B |
| Cash flow | ||
| Cash from operations | −$61.2M | −$77.8M |
| Capital expenditure | $2.3M | $2.0M |
| Free cash flow | −$63.5M | −$79.8M |
| Depreciation and amortization | $1.5M | $1.7M |
| Stock-based compensation | $6.5M | $7.8M |
| Balance sheet | ||
| Cash and short-term investments | $70.5M | $6.7M |
| Total debt | $0.0M | $0.0M |
| Current assets | $74.7M | $15.7M |
| Current liabilities | $16.6M | $21.4M |
| Inventory | $0.5M | $0.2M |
| Property and equipment, net | $4.8M | $5.3M |
| Intangible assets | $0.2M | $0.1M |
| Total assets | $80.7M | $23.0M |
| Total liabilities | $18.0M | $23.3M |
| Preferred stock | $0.0M | $0.0M |
| Shareholders' equity | $62.8M | −$0.1M |
| Margins | ||
| Gross margin | 46.8% | 70.3% |
| Operating margin | −2,899.4% | −4,908.2% |
| EBITDA margin | −2,843.7% | −4,821.4% |
| Net margin | −2,822.5% | −4,921.3% |
| FCF margin | −2,349.5% | −4,169.2% |
| Returns | ||
| Return on capital employed | −122.2% | −5,781.7% |
| Return on equity | −121.6% | −300.5% |
| Return on assets | −94.5% | −181.6% |
| Return on tangible equity | −121.9% | — |
| Growth | ||
| Revenue growth | — | −29.2% |
| Share count change | — | 82.3% |
| Financial health | ||
| Debt / equity | 0.0x | — |
| Interest coverage | −1,667.5x | −1,286.2x |
| Current ratio | 4.5x | 0.7x |
| Quick ratio | 4.5x | 0.7x |
| Capital allocation | ||
| Capex / revenue | 83.8% | 102.1% |
| Stock comp / revenue | 241.2% | 406.8% |
| Quality scores | ||
| Piotroski F-score | — | 3.0 |
| Altman Z'' | −9.3 | −81.6 |
| Accruals ratio | −18.6% | −31.5% |
Source: SEC EDGAR XBRL filings (CIK 0002011514). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.